Table 1.
Clinical and pathologic characteristics of women with oropharyngeal cancer in this study.
| Characteristic | All (N = 372) | No history of Cervical Cancer (N = 339) |
History of Cervical Cancer (N = 33) |
P-valuea |
|---|---|---|---|---|
| Age (mean) | 63.3 | 63.9 | 56.8 | 0.002 |
| Mean pack years | 24.1 | 24.1 | 24.3 | 0.96 |
| T-stage (%) | ||||
| T1 | 22.1 | 22.0 | 23.8 | |
| T2 | 37.7 | 37.2 | 42.9 | |
| T3 | 16.7 | 16.1 | 23.8 | |
| T4 | 23.3 | 24.5 | 9.5 | 0.43 |
| N-stage (%) | ||||
| N0 | 22.0 | 22.2 | 20.0 | |
| N1 | 17.7 | 17.9 | 15.0 | |
| N2 | 54.7 | 54.2 | 60.0 | |
| N3 | 5.5 | 5.6 | 5.0 | 0.97 |
| Tumor subsite (%) | ||||
| Tonsil | 52.9 | 51.9 | 63.6 | 0.34 |
| BOT | 31.9 | 32.4 | 27.2 | |
| Soft palate | 8.6 | 8.6 | 9.1 | |
| PPP | 6.4 | 7.1 | 0 | |
| P16 positive (%) | 56.8 | 54.7 | 76.1 | 0.04 |
a
Denotes statistical significance between patients with or without a history of cervical cancer. BOT, base of tongue; PPP, posterior pharyngeal wall.